Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04963283
Title A Phase II Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Colorado, Denver

colorectal adenocarcinoma


Cabozantinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Hospital Recruiting Aurora Colorado 80012 United States Details
UCHealth Memorial Hospital Central Recruiting Colorado Springs Colorado 80909 United States Details
UCHealth Harmony Campus Recruiting Fort Collins Colorado 80528 United States Details
UCHealth Family Medicine - Greeley Recruiting Greeley Colorado 80634 United States Details
UCHealth Medical Center of the Rockies Recruiting Loveland Colorado 80538 United States Details
*Shaded cells indicate that there was no data available from for the field